Literature DB >> 17012892

Maturation of recombinant hepatitis B virus surface antigen particles.

Qinjian Zhao1, Yang Wang, Daniel Freed, Tong-Ming Fu, Juan A Gimenez, Robert D Sitrin, Michael W Washabaugh.   

Abstract

The major surface antigen of Hepatitis B virus (HBsAg) is a cysteine-rich, lipid-bound protein with 226 amino acids. Recombinant HBsAg (rHBsAg) with associated lipids can self-assemble into 22-nm immunogenic spherical particles, which are used in licensed Hepatitis B vaccines. Little is known about the structural evolvement or maturation upon assembly beyond an elevated level of disulfide formation. In this paper, we further characterized the maturation of HBsAg particles with respect to their degree of cross-linking, morphological changes, and changes in conformational flexibility. The lipid-containing rHBsAg particles undergo KSCN- and heat-induced maturation by formation of additional intra- and inter-molecular disulfide bonds. Direct measurements with atomic force microscopy (AFM) revealed morphological changes upon maturation through KSCN-induced and heat-/storage-incurred oxidative refolding. Particle uniformity and regularity was greatly improved, and protrusions formed by the protein subunits were more prominent on the surface of the mature particles. Decreased conformational flexibility in the mature rHBsAg particles was demonstrated by millisecond-scale unfolding kinetics in the presence of an environment-sensitive conformation probe. Both the accessible hydrophobic cavities under native conditions and the changeable hydrophobic cavities upon denaturant-induced unfolding showed substantial decrease upon maturation of the rHBsAg particles. These changes in the structural properties may be critical for the antigenicity and immuno-genicity of this widely-used vaccine component.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17012892     DOI: 10.4161/hv.2.4.3015

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  11 in total

1.  DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease.

Authors:  Purevdorj B Olkhanud; Mohammed Mughal; Koichi Ayukawa; Enkhzol Malchinkhuu; Monica Bodogai; Neil Feldman; Sarah Rothman; Jong-Hwan Lee; Srinivasulu Chigurupati; Eitan Okun; Kunio Nagashima; Mark P Mattson; Arya Biragyn
Journal:  Vaccine       Date:  2012-01-14       Impact factor: 3.641

2.  Toward the development of monoclonal antibody-based assays to probe virion-like epitopes in hepatitis B vaccine antigen.

Authors:  Yibin Zhu; Tianying Zhang; Jinghua Zhao; Zusen Weng; Quan Yuan; Shaowei Li; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2014-02-05       Impact factor: 3.452

3.  Physiological response of Pichia pastoris GS115 to methanol-induced high level production of the Hepatitis B surface antigen: catabolic adaptation, stress responses, and autophagic processes.

Authors:  Ana Leticia Vanz; Heinrich Lünsdorf; Ahmad Adnan; Manfred Nimtz; Chandrasekhar Gurramkonda; Navin Khanna; Ursula Rinas
Journal:  Microb Cell Fact       Date:  2012-08-08       Impact factor: 5.328

4.  Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine.

Authors:  Anke M Mulder; Bridget Carragher; Victoria Towne; Yuan Meng; Yang Wang; Lance Dieter; Clinton S Potter; Michael W Washabaugh; Robert D Sitrin; Qinjian Zhao
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

5.  Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.

Authors:  Ankur Poddar; Viswanathan Ramasamy; Rahul Shukla; Ravi Kant Rajpoot; Upasana Arora; Swatantra K Jain; Sathyamangalam Swaminathan; Navin Khanna
Journal:  BMC Biotechnol       Date:  2016-06-14       Impact factor: 2.563

6.  Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.

Authors:  Shailendra Mani; Lav Tripathi; Rajendra Raut; Poornima Tyagi; Upasana Arora; Tarani Barman; Ruchi Sood; Alka Galav; Wahala Wahala; Aravinda de Silva; Sathyamangalam Swaminathan; Navin Khanna
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

7.  Induction of an effective anti-Amyloid-β humoral response in aged mice.

Authors:  Tomer Illouz; Ravit Madar; Tamir Hirsh; Arya Biragyn; Eitan Okun
Journal:  Vaccine       Date:  2021-07-20       Impact factor: 4.169

8.  Restoring microglial and astroglial homeostasis using DNA immunization in a Down Syndrome mouse model.

Authors:  Tomer Illouz; Ravit Madar; Arya Biragyn; Eitan Okun
Journal:  Brain Behav Immun       Date:  2018-10-25       Impact factor: 7.217

Review 9.  Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Authors:  Joan Kha-Tu Ho; Beena Jeevan-Raj; Hans-Jürgen Netter
Journal:  Viruses       Date:  2020-01-21       Impact factor: 5.048

10.  Hepatitis B virus detected in paper currencies in a densely populated city of India: A plausible source of horizontal transmission?

Authors:  Palashpriya Das; Ruchi Supekar; Ritika Chatterjee; Subrata Roy; Anisa Ghosh; Subhajit Biswas
Journal:  World J Hepatol       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.